Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Novel oxazolidinone antibacterial agents reported by Bayer

Aug. 9, 1996

Antibacterial peptides from Sanwa Kagaku

Aug. 9, 1996

Beta-Lactamase inhibitors for treatment of penicillin-resistant infections

Aug. 9, 1996

Licensing agreement signed for rifaximin

Aug. 9, 1996

SmithKline Beecham acquires worldwide rights to Cantab's TA-GW vaccine

July 26, 1996

Chlorhexidine gluconate effective in reducing incidence of nosocomial respiratory tract infections

July 26, 1996

Sequus and Zeneca restructure Amphotec marketing agreement

July 26, 1996

Xoma claims rBPI21 + antibiotic combination for Gram-negative infections

July 26, 1996

Carbapenem derivatives with antibacterial activity claimed by Yamanouchi

July 26, 1996

Cantab's DISC HSV-2 cleared in U.K. for testing in genital herpes

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...